Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PowerShares FTSE RAFI US 1000 Portfolio (PRF)

Delayed Data
As of 2:50pm ET
 +0.2797 / +0.35%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the FTSE RAFI US 1000 Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in common stocks that comprise the underlying index. The underlying index was composed of approximately 1,000 U.S. stocks that FTSE International Limited and Research Affiliates LLC strictly in accordance with its guidelines and mandated procedures, included to track the performance of the largest U.S. equity stocks based on the following four fundamental measures: book value, cash flow, sales and dividends.

No recent news for PowerShares FTSE RAFI US 1000 Portfolio.


1 month-2.91% 3 years+7.71%
3 months-10.41% 5 years+8.29%
1 year-10.67% Since inception+6.61%
Data through 02/10/2016

Quote Details

Previous close$79.38
Open day’s range79.47 – 80.44
Net asset value (NAV)79.36 (02/09/2016)
Daily volume149,042
Average volume (3 months)239,611
Data as of 2:50pm ET, 02/10/2016

Peer Comparisonvs. Large value ETFs

Performance 5-yr return+8.29%+11.50%
Expense Gross exp ratio0.41%0.35%
Risk 5 year sharpe ratio0.810.92
Net assets$3.9B$2.0B
Average market cap$48.5B$78.8B
Average P/E16.216.4
Dividend / Share--0.27%


VTV Vanguard Value Index Fund ETF Shares
VLU SPDR® S&P 1500 Value Tilt ETF
SCHV Schwab U.S. Large-Cap Value ETF™


Top 5 Sectors
Portfolio weighting
Financial service 21.02%
Energy 13.26%
Industrial materials 12.64%
Consumer goods 9.88%
Healthcare 8.53%
Top 10 Holdings
Portfolio weighting
XOM Exxon Mobil3.01%
T AT&T2.38%
GE General Electric2.20%
JPM JPMorgan Chase2.01%
CVX Chevron1.88%
MSFT Microsoft1.64%
WFC Wells Fargo1.58%
VZ Verizon1.54%
BRKB Berkshire Hathaway1.44%
JNJ Johnson & Johnson1.42%

Partner Offers